These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25978614)

  • 21. Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.
    Dlugosz A; Nowak P; D'Amato M; Mohammadian Kermani G; Nyström J; Abdurahman S; Lindberg G
    Neurogastroenterol Motil; 2015 Dec; 27(12):1747-54. PubMed ID: 26387872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
    Barbaro MR; Di Sabatino A; Cremon C; Giuffrida P; Fiorentino M; Altimari A; Bellacosa L; Stanghellini V; Barbara G
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G439-47. PubMed ID: 26744473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lidocaine ameliorates intestinal barrier dysfunction in irritable bowel syndrome by modulating corticotropin-releasing hormone receptor 2.
    Wang Y; Qiao M; Yao X; Feng Z; Hu R; Chen J; Liu L; Liu J; Sun Y; Guo Y
    Neurogastroenterol Motil; 2023 Nov; 35(11):e14677. PubMed ID: 37736684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
    Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
    Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
    Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
    Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
    Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.
    El-Salhy M; Hatlebakk JG; Hausken T
    World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS.
    Russo F; Chimienti G; Riezzo G; Linsalata M; D'Attoma B; Clemente C; Orlando A
    Dis Markers; 2018; 2018():1827937. PubMed ID: 30622656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions.
    Camilleri M; Oduyebo I; Halawi H
    Am J Physiol Gastrointest Liver Physiol; 2016 Nov; 311(5):G777-G784. PubMed ID: 27609770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC; Dong L; Wang Y; Wang SH; Cao MB
    Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome].
    Zhu J; Luo HS; Chen L; Zhou T
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2713-7. PubMed ID: 20137275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS.
    Wilcz-Villega E; McClean S; O'Sullivan M
    Neurogastroenterol Motil; 2014 Mar; 26(3):316-25. PubMed ID: 24286617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients.
    Ostertag D; Annahazi A; Krueger D; Michel K; Demir IE; Ceyhan GO; Zeller F; Schemann M
    Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28374503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in serotonin metabolism in the irritable bowel syndrome.
    Thijssen AY; Mujagic Z; Jonkers DM; Ludidi S; Keszthelyi D; Hesselink MA; Clemens CH; Conchillo JM; Kruimel JW; Masclee AA
    Aliment Pharmacol Ther; 2016 Jan; 43(2):272-82. PubMed ID: 26538292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
    Willot S; Gauthier C; Patey N; Faure C
    Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irritable bowel syndrome and basal serum tryptase: correlation between subtype, severity, and comorbidities. A pilot study.
    Ciriza de Los Ríos C; Castel de Lucas I; Canga Rodríguez-Valcárcel F; Diéguez Pastor MDC; de Las Cuevas Moreno N; Rey Díaz-Rubio E
    Rev Esp Enferm Dig; 2022 Jan; 114(1):22-27. PubMed ID: 33562988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.